Gauging the Success of Relapsed-Refractory Hodgkin Lymphoma Treatment
Dr. John Sweetenham, executive medical director at the Huntsman Cancer Institute, discusses the importance of clinic follow-up, regular surveillance and relatively frequent... Learn More
Advances in the Treatment and Management of Hodgkin Lymphoma
Researchers are hoping that an improved understanding of Hodgkin Lymphoma at the biological level will translate to new, more effective treatment options.... Learn More
How to Cope with Second-Line Hodgkin Lymphoma Treatments
Hodgkin lymphoma patient advocates Meredith Wooten and Suzanne Hyte share how they coped with additional treatments and side effects after relapsing. From... Learn More